Full name: Filip Van den Bosch
Current country: Belgium
Membership level: Full
Type of membership: EC
Number of publications: 5
The value of magnetic resonance imaging for assessing disease extent and prediction of relapse in early peripheral spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33982902/
Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine (2021)
https://pubmed.ncbi.nlm.nih.gov/33115761/
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34850859/
Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32661321/
High rate of drug-free remission after induction therapy with Golimumab in early peripheral spondyloarthritis. (2018)
https://pubmed.ncbi.nlm.nih.gov/29806090/